Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Melissa Frey, MD, MS
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Newyork-Presbyterian Weill Cornell Medicine
Brooklyn, New York, United States
Not, yet, recruiting - Reproductive Medicine
Brooklyn, New York, United States
Recruiting - Reproductive Medicine
New York, New York, United States
Recruiting - Weill Cornell Medicine
New York, New York, United States
Melissa Frey, MD, MSRecruiting - Newyork-Presbyterian Weill Cornell Medicine Queens
Queens, New York, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Sept 2025
- Primary completion
- 30 Jun 2027
- Completion
- 31 Dec 2028
- Last update posted
- 26 Dec 2025
- Registered enrollment
- 550
- Registry id
- NCT07052266
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.